Visionary Pharmaceuticals
PrivateLast Round
Grant
Nov 1, 2020
Total Funding Raised
$2.5M
Company Overview
Visionary Pharmaceuticals operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Grant round in November 2020.
Visionary Pharmaceuticals is a biotechnology company that develops small molecule oral therapeutics for the treatment of autoimmune diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Visionary Pharmaceuticals Comparables
Compare Visionary Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nimbus Therapeutics | 81% | |
| Harmonic Discovery | 80% | |
| Iambic Therapeutics | 80% |
For institutional investors. Book with your work email.
Visionary Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2020 | ||||
| Grant | Jul 7, 2016 | ||||
| Grant | Sep 8, 2014 | ||||
| Grant | Mar 5, 2013 | ||||
| Seed | Jul 27, 2011 |
For institutional investors. Book with your work email.
Visionary Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| HealthCare Ventures | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| National Center for Advancing Translational Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2020
$100K grant from National Center for Advancing Translational Sciences.
For institutional investors. Book with your work email.
Visionary Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Visionary Pharmaceuticals's valuation, stock price, and market status.
Is Visionary Pharmaceuticals a public or private company?
Visionary Pharmaceuticals is a private company.
What is the current stock price of Visionary Pharmaceuticals?
Visionary Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Visionary Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Visionary Pharmaceuticals worth (valuation)?
Valuation information for Visionary Pharmaceuticals is not publicly available.
Can I buy Visionary Pharmaceuticals stock?
Visionary Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Visionary Pharmaceuticals's last funding round?
Visionary Pharmaceuticals's most recent funding round was Grant on November 1, 2020.
Who are the main investors in Visionary Pharmaceuticals?
Key investors in Visionary Pharmaceuticals include NIH RADx, HealthCare Ventures, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences.
Will Visionary Pharmaceuticals IPO soon?
No public IPO plans have been announced for Visionary Pharmaceuticals.
How can I track Visionary Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Visionary Pharmaceuticals's shares on secondary markets.